Skip to content
English
עברית
TRIAL-IN Pharma
  • Home
  • About Us
    • A word from our General Manager
    • About the Staff
    • FAQ
    • Media
    • Lectures to organizations and congresses
    • Digital Health
  • Our Service
    • Worldwide Innovative Cancer Drugs and Treatments
    • Access to Treatment Consultation and Support
  • New Treatments
    • Clinical Trials
    • Compassionate Drugs
    • Case Studies or Case Reports
    • Articles
  • Cancer Types
    • Cancer: What is Cancer?
    • Bladder Cancer
    • Breast Cancer
    • Cervical Cancer
    • Colorectal Cancer
    • DIPG – Brain Stem Cancer
    • Gastric Cancer
    • Glioblastoma
    • Kidney Cancer
    • Liver Cancer >>
    • Cholangiocarcinoma
    • Lung Cancer >>
      • Non Small Cell Lung Cancer, NSCLC
      • Small Cell Lung Cancer, SCLC
      • Mesothelioma
    • Ovarian Cancer
    • Pancreatic Cancer
    • Prostate Cancer
    • Skin Cancer and Melanoma
    • Thyroid Cancer
  • Cancer Glossary
  • Contact Us
  • עברית
  • Toggle website search
Menu Close
  • Home
  • About Us
    • A word from our General Manager
    • About the Staff
    • FAQ
    • Media
    • Lectures to organizations and congresses
    • Digital Health
  • Our Service
    • Worldwide Innovative Cancer Drugs and Treatments
    • Access to Treatment Consultation and Support
  • New Treatments
    • Clinical Trials
    • Compassionate Drugs
    • Case Studies or Case Reports
    • Articles
  • Cancer Types
    • Cancer: What is Cancer?
    • Bladder Cancer
    • Breast Cancer
    • Cervical Cancer
    • Colorectal Cancer
    • DIPG – Brain Stem Cancer
    • Gastric Cancer
    • Glioblastoma
    • Kidney Cancer
    • Liver Cancer >>
    • Cholangiocarcinoma
    • Lung Cancer >>
      • Non Small Cell Lung Cancer, NSCLC
      • Small Cell Lung Cancer, SCLC
      • Mesothelioma
    • Ovarian Cancer
    • Pancreatic Cancer
    • Prostate Cancer
    • Skin Cancer and Melanoma
    • Thyroid Cancer
  • Cancer Glossary
  • Contact Us
  • עברית
  • Toggle website search
Read more about the article Gastric Cancer – Enhertu in HER2-Positive patients
Gastric Cancer - Enhertu in HER2-Positive patients

Gastric Cancer – Enhertu in HER2-Positive patients

  • Post author:NIR EREZ
  • Post published:June 9, 2020
  • Post category:Gastric Cancer

Background Enhertu is a conjugate of an antibody which is anti-HER2 and chemo drug. Enhertu may have efficacy in patients with HER2-positive advanced gastric cancer. In a phase II trial,…

Continue ReadingGastric Cancer – Enhertu in HER2-Positive patients

General Info

  • About Us
  • A word from our General Manager
  • About the Staff
  • Media
  • FAQ
  • Terms of Use
  • Contact Us

Popular topics

Bladder Cancer Breast Cancer Cancer: What is Cancer? Case Studies or Case Reports Cervical Cancer Cholangiocarcinoma Clinical Trials Colon Cancer Colorectal Cancer Compassionate Drugs DIPG (brain stem cancer) Endometrial Cancer Esophageal Cancer Gastric Cancer Glioblastoma Head and Neck Cancer Kidney Cancer Liver Cancer Lung Cancer Mesothelioma Non Small Cell Lung Cancer, NSCLC Ovarian Cancer Pancreatic Cancer Prostate Cancer Sarcoma Skin Cancer and Melanoma Small Cell Lung Cancer, SCLC Thyroid Cancer

Contact Info

  • Improve therapeutic outcomes, prolong life and quality of life, is our main business. Feel comfortable to contact us for any request or clarification.
  • Phone:+44.2082.426.039Opens in your application
  • Email:contact@trial-in.comOpens in your application

Follow us on Facebook

Designed and built by WP4All